FI
ZYME icon

Fosun International’s Zymeworks ZYME Stock Holding History

Fosun International’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-88,008
Closed -$1.03M – 333
2018
Q4 		$1.03M Buy
+88,008
New +$1.15M 0.06% 133

Other funds holding ZYME

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fosun International's ZYME Position: Q1 2019 in Review

Fosun International sold out of Zymeworks (ZYME) in Q1 2019, closing a stake of 88,008 shares — an estimated $1.03M sold.

Fosun International first reported a position in ZYME in Q4 2018 and held it in 1 quarter. The position peaked at $1.03M in Q4 2018. 47 funds tracked by Wall St. Rank hold ZYME as of Q1 2019.

  • Fosun International reported no remaining Zymeworks position as of Q1 2019 after selling out during the quarter.
  • Fosun International sold 88,008 Zymeworks shares in Q1 2019, an estimated $1.03M.
  • Fosun International first reported a position in Zymeworks in Q4 2018 and held it in 1 quarter.
  • Fosun International's Zymeworks position peaked at $1.03M in Q4 2018.
  • 47 funds tracked by Wall St. Rank held Zymeworks as of Q1 2019.

Based on Fosun International's 13F filing for Q1 2019, filed 10 May 2019.